Missouris C G, Allen C M, Balen F G, Buckenham T, Lees W R, MacGregor G A
Department of Medicine, St George's Hospital Medical School, London, UK.
J Hypertens. 1996 Apr;14(4):519-24.
Our aim was to evaluate duplex ultrasound imaging in the identification of renal artery stenosis using a new technique to enhance the recorded Doppler signal.
Colour Doppler studies of interlobar renal arteries were performed before and after enhancement using an intravenous contrast of galactose microparticle suspension containing microbubbles (Levovist, Schering) in patients with angiographically confirmed renal artery stenosis.
Blood Pressure Unit, St. George's Hospital Medical School, and Department of Radiology. The Middlesex Hospital, London, UK.
Twenty-one consecutive hypertensive patients in whom the diagnosis of renal artery stenosis was made on digital subtraction angiography.
The diagnosis of haemodynamically significant renal artery stenosis (> or = 60% on angiography).
With Levovist, there was a 20 db increase in the Doppler intensity and, as a result, intrarenal signals were much more clearly delineated and distinct spectral waveforms were obtained from all but one kidney, which was occluded. Significant associations were found between the degree of stenosis (as assessed by angiography) and the following Doppler parameters: diastolic velocity (F = 7.6; P < 0.01), acceleration time (F = 33.5, < 0.0001), peak systolic velocity (F = 37.7, P < 0.0001) and acceleration (F = 60.0; P < 0.0001). Without enhancement, there were five false-positive and two false-negative examinations (sensitivity 85%; specificity 79%) using the acceleration cut-off value of 3.5 m/s2 to identify haemodynamically significant renal artery stenosis (> or = 60% on angiography). After contrast enhancement, there were only three false-positive and one false-negative examinations (sensitivity 94% and specificity of 88%) using the acceleration cut-off value of 3.75 m/s2 and the examination time was reduced by approximately half (sensitivity and specificity of 90% using the acceleration cut-off value of 3.5 m/s2).
Our results suggest that renal duplex scanning using contrast enhancement is a promising new non-invasive technique in screening patients with suspected renal artery stenosis. Contrast enhancement produces more reproducible spectral waveforms, improves accuracy and halves the examination time.
我们的目的是评估使用一种增强记录的多普勒信号的新技术的双功超声成像在识别肾动脉狭窄中的作用。
在经血管造影证实患有肾动脉狭窄的患者中,在使用含微泡的半乳糖微粒悬浮液(Levovist,先灵公司)静脉造影剂增强前后,对肾叶间动脉进行彩色多普勒研究。
圣乔治医院医学院血压科和放射科。英国伦敦米德尔塞克斯医院。
21例经数字减影血管造影诊断为肾动脉狭窄的连续高血压患者。
血流动力学显著肾动脉狭窄(血管造影显示≥60%)的诊断。
使用Levovist后,多普勒强度增加20分贝,结果除一个肾闭塞外,其余所有肾脏的肾内信号均更清晰地显示,且获得了清晰的频谱波形。在狭窄程度(通过血管造影评估)与以下多普勒参数之间发现了显著相关性:舒张期速度(F = 7.6;P < 0.01)、加速时间(F = 33.5,< 0.0001)、收缩期峰值速度(F = 37.7,P < 0.0001)和加速度(F = 60.0;P < 0.)。在未增强的情况下,使用3.5 m/s2的加速度截断值来识别血流动力学显著肾动脉狭窄(血管造影显示≥60%)时,有5例假阳性和2例假阴性检查(敏感性85%;特异性79%)。造影剂增强后,使用3.75 m/s2的加速度截断值时,仅有3例假阳性和1例假阴性检查(敏感性94%,特异性88%),且检查时间减少了约一半(使用3.5 m/s2的加速度截断值时敏感性和特异性为90%)。
我们的结果表明,使用造影剂增强的肾双功扫描是一种有前景的用于筛查疑似肾动脉狭窄患者的新无创技术。造影剂增强可产生更可重复的频谱波形,提高准确性并将检查时间减半。